Galectin Therapeutics
GALT
GALT
71 hedge funds and large institutions have $26.9M invested in Galectin Therapeutics in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 26 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
50% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 26
Holders
71
Holding in Top 10
–
Calls
$648K
Puts
$255K
Top Buyers
| 1 | +$283K | |
| 2 | +$121K | |
| 3 | +$91.2K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$62.4K |
| 5 |
WAM
Wealthspire Advisors (Maryland)
Potomac,
Maryland
|
+$37K |
Top Sellers
| 1 | -$241K | |
| 2 | -$90.5K | |
| 3 | -$86K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$75.8K |
| 5 |
SG Americas Securities
New York
|
-$62K |